| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.677 | 0.027 | 0.703 | Caspase 9 stimulant | 0.703 0.024 CID_57515736 | CID_57515736 | |
| 0.577 | 0.01 | 0.585 | GABA C receptor rho-3 antagonist | 0.585 0.009 CID_57515736 | CID_57515736 | |
| 0.448 | 0.011 | 0.448 | Calcium channel activator | 0.411 0.021 CID_57515736 | ||
| 0.437 | 0.016 | 0.588 | Peroxidase inhibitor | 0.588 0.005 CID_57515736 | CID_57515736 | |
| 0.392 | 0.002 | 0.392 | Toll-Like receptor 3 antagonist | 0.153 0.014 CID_57515736 | ||
| 0.406 | 0.045 | 0.44 | 5 Hydroxytryptamine release stimulant | 0.44 0.038 CID_57515736 | CID_57515736 | |
| 0.424 | 0.066 | 0.485 | Calcium channel L-type activator | 0.485 0.034 CID_57515736 | CID_57515736 | |
| 0.357 | 0.008 | 0.357 | Growth factor agonist | 0.266 0.025 CID_57515736 | ||
| 0.401 | 0.075 | 0.412 | Histamine release inhibitor | 0.412 0.069 CID_57515736 | CID_57515736 | |
| 0.336 | 0.012 | 0.336 | Tumour necrosis factor antagonist | 0.176 0.071 CID_57515736 | ||
| 0.352 | 0.04 | 0.352 | DNA damaging | 0.315 0.052 CID_57515736 | ||
| 0.366 | 0.054 | 0.366 | Caspase 3 stimulant | 0.248 0.114 CID_57515736 | ||
| 0.319 | 0.028 | 0.319 | ErbB-1 antagonist | |||
| 0.353 | 0.063 | 0.353 | Cholesterol antagonist | 0.329 0.074 CID_57515736 | ||
| 0.305 | 0.02 | 0.305 | MAO inhibitor | |||
| 0.39 | 0.109 | 0.481 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.481 0.043 CID_57515736 | CID_57515736 | |
| 0.331 | 0.057 | 0.331 | Lipoxygenase inhibitor | |||
| 0.29 | 0.016 | 0.29 | MAO A inhibitor | 0.105 0.061 CID_57515736 | ||
| 0.305 | 0.035 | 0.305 | Platelet aggregation inhibitor | |||
| 0.367 | 0.101 | 0.449 | 5 Hydroxytryptamine release inhibitor | 0.449 0.052 CID_57515736 | CID_57515736 | |
| 0.275 | 0.016 | 0.275 | Toll-Like receptor 9 antagonist | 0.163 0.055 CID_57515736 | ||
| 0.303 | 0.049 | 0.443 | Superoxide dismutase inhibitor | 0.443 0.02 CID_57515736 | CID_57515736 | |
| 0.348 | 0.094 | 0.398 | MAP kinase kinase 6 inhibitor | 0.398 0.059 CID_57515736 | CID_57515736 | |
| 0.295 | 0.049 | 0.295 | Pyruvate kinase inhibitor | 0.247 0.062 CID_57515736 | ||
| 0.25 | 0.008 | 0.527 | Porphobilinogen synthase inhibitor | 0.527 0.003 CID_57515736 | CID_57515736 | |
| 0.304 | 0.064 | 0.304 | Hypoxia-inducible factor 1 alpha inhibitor | 0.296 0.067 CID_57515736 | ||
| 0.254 | 0.017 | 0.254 | Aldehyde dehydrogenase inhibitor | 0.215 0.024 CID_57515736 | ||
| 0.246 | 0.013 | 0.254 | GABA C receptor rho-2 antagonist | 0.254 0.011 CID_57515736 | CID_57515736 | |
| 0.26 | 0.033 | 0.278 | Neurotrophic factor enhancer | 0.278 0.025 CID_57515736 | CID_57515736 | |
| 0.238 | 0.017 | 0.238 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.221 | 0.003 | 0.221 | Granulocyte macrophage colony stimulating factor agonist | 0.167 0.004 CID_57515736 | ||
| 0.223 | 0.008 | 0.223 | Stem cell growth factor agonist | |||
| 0.251 | 0.037 | 0.251 | I kappa B kinase epsilon inhibitor | 0.21 0.063 CID_57515736 | ||
| 0.226 | 0.013 | 0.226 | Nav1.6 sodium channel blocker | 0.145 0.06 CID_57515736 | ||
| 0.231 | 0.019 | 0.231 | MAO B inhibitor | |||
| 0.241 | 0.029 | 0.241 | Vascular endothelial growth factor 3 antagonist | |||
| 0.224 | 0.016 | 0.224 | Antibacterial (Helicobacter pylori) | 0.108 0.103 CID_57515736 | ||
| 0.242 | 0.038 | 0.268 | Nitric-oxide synthase stimulant | 0.268 0.022 CID_57515736 | CID_57515736 | |
| 0.213 | 0.014 | 0.213 | Platelet activating factor alpha antagonist | |||
| 0.22 | 0.022 | 0.22 | Platelet activating factor antagonist | |||
| 0.264 | 0.073 | 0.264 | Aryl hydrocarbon receptor agonist | 0.261 0.074 CID_57515736 | ||
| 0.258 | 0.07 | 0.258 | Gastrin inhibitor | 0.247 0.083 CID_57515736 | ||
| 0.212 | 0.025 | 0.212 | Sodium channel (voltage-gated) blocker | 0.107 0.102 CID_57515736 | ||
| 0.279 | 0.092 | 0.279 | 12-Lipoxygenase inhibitor | 0.261 0.103 CID_57515736 | ||
| 0.199 | 0.012 | 0.199 | Gastric antisecretory | 0.092 0.076 CID_57515736 | ||
| 0.238 | 0.055 | 0.238 | DNA methylase inhibitor | |||
| 0.213 | 0.03 | 0.213 | Insulin secretagoues | |||
| 0.331 | 0.149 | 0.331 | MAP kinase 1 inhibitor | 0.288 0.194 CID_57515736 | ||
| 0.19 | 0.009 | 0.19 | Macrophage migration inhibitory factor inhibitor | 0.09 0.042 CID_57515736 | ||
| 0.281 | 0.103 | 0.281 | Angiogenesis inhibitor | |||
| 0.206 | 0.028 | 0.206 | Toll-Like receptor antagonist | 0.124 0.079 CID_57515736 | ||
| 0.293 | 0.119 | 0.293 | Calpain 2 inhibitor | |||
| 0.177 | 0.004 | 0.177 | Oleamide hydrolase inhibitor | 0.045 0.032 CID_57515736 | ||
| 0.174 | 0.005 | 0.174 | Xanthine dehydrogenase inhibitor | |||
| 0.176 | 0.007 | 0.176 | Myeloperoxidase inhibitor | |||
| 0.199 | 0.031 | 0.21 | Mannose-6-phosphate isomerase inhibitor | 0.21 0.026 CID_57515736 | CID_57515736 | |
| 0.212 | 0.044 | 0.227 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 CID_57515736 | CID_57515736 | |
| 0.172 | 0.006 | 0.172 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.036 CID_57515736 | ||
| 0.225 | 0.064 | 0.254 | MAP kinase kinase 3 inhibitor | 0.254 0.028 CID_57515736 | CID_57515736 | |
| 0.208 | 0.047 | 0.208 | 3C-like protease (Human coronavirus) inhibitor | 0.189 0.058 CID_57515736 | ||
| 0.176 | 0.015 | 0.176 | Sphingomyelinase inhibitor | 0.089 0.074 CID_57515736 | ||
| 0.167 | 0.008 | 0.167 | Amidase inhibitor | |||
| 0.173 | 0.016 | 0.173 | DNA repair enzyme inhibitor | 0.107 0.104 CID_57515736 | ||
| 0.191 | 0.036 | 0.191 | Sodium channel blocker | |||
| 0.239 | 0.084 | 0.239 | Hypoglycemic | |||
| 0.189 | 0.038 | 0.189 | Interleukin 1 antagonist | 0.173 0.045 CID_57515736 | ||
| 0.159 | 0.008 | 0.159 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.138 0.009 CID_57515736 | ||
| 0.197 | 0.047 | 0.197 | Growth factor antagonist | |||
| 0.153 | 0.004 | 0.153 | Sodium/calcium exchanger inhibitor | |||
| 0.168 | 0.019 | 0.168 | Heat shock protein 70 antagonist | 0.155 0.036 CID_57515736 | ||
| 0.173 | 0.027 | 0.173 | Xanthine oxidase inhibitor | 0.087 0.077 CID_57515736 | ||
| 0.23 | 0.085 | 0.23 | Calpain inhibitor | 0.169 0.15 CID_57515736 | ||
| 0.165 | 0.02 | 0.165 | HIV-1 integrase (Overall Integration) inhibitor | 0.099 0.055 CID_57515736 | ||
| 0.161 | 0.019 | 0.161 | Hepatocyte growth factor antagonist | |||
| 0.158 | 0.016 | 0.158 | ErbB-2 antagonist | |||
| 0.156 | 0.014 | 0.156 | Phosphodiesterase 3A inhibitor | |||
| 0.161 | 0.022 | 0.161 | Nav1.5 sodium channel blocker | |||
| 0.26 | 0.12 | 0.312 | Vasodilator, peripheral | 0.312 0.091 CID_57515736 | CID_57515736 | |
| 0.18 | 0.041 | 0.18 | NADPH oxidase inhibitor | 0.106 0.102 CID_57515736 | ||
| 0.168 | 0.029 | 0.168 | Beta amyloid protein antagonist | 0.121 0.066 CID_57515736 | ||
| 0.154 | 0.015 | 0.26 | CYP2A6 inhibitor | 0.26 0.004 CID_57515736 | CID_57515736 | |
| 0.177 | 0.039 | 0.183 | CF transmembrane conductance regulator agonist | 0.183 0.034 CID_57515736 | CID_57515736 | |
| 0.235 | 0.097 | 0.329 | 5 Hydroxytryptamine uptake stimulant | 0.329 0.033 CID_57515736 | CID_57515736 | |
| 0.155 | 0.018 | 0.155 | Platelet growth factor antagonist | |||
| 0.203 | 0.067 | 0.203 | Focal adhesion kinase 2 inhibitor | 0.157 0.119 CID_57515736 | ||
| 0.162 | 0.025 | 0.162 | Death-associated protein kinase 1 inhibitor | 0.122 0.107 CID_57515736 | ||
| 0.145 | 0.01 | 0.145 | Leukotriene synthesis inhibitor | |||
| 0.204 | 0.069 | 0.204 | Insulin sensitizer | |||
| 0.203 | 0.068 | 0.203 | DNA methyltransferase I inhibitor | |||
| 0.16 | 0.026 | 0.16 | EphA2 antagonist | |||
| 0.152 | 0.018 | 0.152 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.122 0.028 CID_57515736 | ||
| 0.153 | 0.019 | 0.153 | Alcohol dehydrogenase inhibitor | 0.145 0.022 CID_57515736 | ||
| 0.154 | 0.021 | 0.154 | Phosphodiesterase IV inhibitor | 0.11 0.038 CID_57515736 | ||
| 0.132 | 0.002 | 0.132 | Free fatty acid receptor 1 antagonist | 0.042 0.014 CID_57515736 | ||
| 0.178 | 0.048 | 0.178 | Activin receptor-like kinase 2 inhibitor | 0.143 0.072 CID_57515736 | ||
| 0.155 | 0.027 | 0.155 | Carbonic anhydrase III inhibitor | 0.096 0.066 CID_57515736 | ||
| 0.162 | 0.034 | 0.162 | Ephrin antagonist | |||
| 0.147 | 0.018 | 0.21 | Acetylcholine release stimulant | 0.21 0.004 CID_57515736 | CID_57515736 | |
| 0.159 | 0.031 | 0.159 | GABA receptor agonist | 0.14 0.042 CID_57515736 | ||
| 0.162 | 0.035 | 0.162 | Histone deacetylase class III inhibitor | |||
| 0.16 | 0.036 | 0.26 | Cystathionine beta-synthase inhibitor | 0.26 0.014 CID_57515736 | CID_57515736 | |
| 0.153 | 0.029 | 0.153 | Carbonic anhydrase XV inhibitor | 0.098 0.069 CID_57515736 | ||
| 0.143 | 0.019 | 0.143 | Glutamate receptor agonist | 0.07 0.063 CID_57515736 | ||
| 0.197 | 0.074 | 0.197 | Histone acetyltransferase inhibitor | 0.191 0.083 CID_57515736 | ||
| 0.163 | 0.041 | 0.163 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.178 | 0.058 | 0.178 | Cytidine deaminase inhibitor | 0.138 0.084 CID_57515736 | ||
| 0.195 | 0.075 | 0.195 | Non-steroidal antiinflammatory agent | 0.138 0.134 CID_57515736 | ||
| 0.131 | 0.013 | 0.131 | Nicotinic alpha4beta2 receptor antagonist | 0.109 0.024 CID_57515736 | ||
| 0.174 | 0.057 | 0.174 | Neurotensin receptor agonist | 0.16 0.079 CID_57515736 | ||
| 0.207 | 0.09 | 0.239 | RNA-directed DNA polymerase inhibitor | 0.239 0.057 CID_57515736 | CID_57515736 | |
| 0.136 | 0.02 | 0.167 | Histamine N-methyltransferase inhibitor | 0.167 0.009 CID_57515736 | CID_57515736 | |
| 0.154 | 0.038 | 0.154 | Interleukin 1b antagonist | |||
| 0.164 | 0.049 | 0.164 | MAP kinase 3 inhibitor | 0.149 0.069 CID_57515736 | ||
| 0.12 | 0.005 | 0.141 | Glutamate (mGluR7) antagonist | 0.141 0.003 CID_57515736 | CID_57515736 | |
| 0.127 | 0.013 | 0.127 | Histone deacetylase SIRT2 inhibitor | |||
| 0.148 | 0.035 | 0.148 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.1 CID_57515736 | ||
| 0.148 | 0.035 | 0.154 | Interleukin 8 antagonist | 0.154 0.032 CID_57515736 | CID_57515736 | |
| 0.143 | 0.032 | 0.143 | Mediator release inhibitor | |||
| 0.13 | 0.02 | 0.13 | GABA A receptor agonist | 0.102 0.036 CID_57515736 | ||
| 0.124 | 0.017 | 0.179 | Phenylalanine 4-hydroxylase inhibitor | 0.179 0.008 CID_57515736 | CID_57515736 | |
| 0.125 | 0.019 | 0.125 | Glutamate release inhibitor | 0.089 0.065 CID_57515736 | ||
| 0.138 | 0.032 | 0.138 | Beta glucuronidase inhibitor | 0.114 0.052 CID_57515736 | ||
| 0.12 | 0.015 | 0.12 | Caspase 7 inhibitor | 0.102 0.026 CID_57515736 | ||
| 0.168 | 0.063 | 0.168 | Cyclin-dependent kinase 3 inhibitor | 0.157 0.081 CID_57515736 | ||
| 0.159 | 0.055 | 0.159 | Cytokine production inhibitor | 0.157 0.057 CID_57515736 | ||
| 0.12 | 0.016 | 0.12 | Benzodiazepine agonist | 0.086 0.035 CID_57515736 | ||
| 0.12 | 0.017 | 0.12 | Nav1.7 sodium channel blocker | |||
| 0.133 | 0.03 | 0.171 | GABA C receptor rho-1 antagonist | 0.171 0.014 CID_57515736 | CID_57515736 | |
| 0.106 | 0.004 | 0.106 | Cytokine production stimulant | 0.057 0.016 CID_57515736 | ||
| 0.108 | 0.006 | 0.108 | TRPM8 blocker | |||
| 0.156 | 0.054 | 0.293 | Phosphodiesterase inhibitor | 0.293 0.015 CID_57515736 | CID_57515736 | |
| 0.113 | 0.012 | 0.113 | Prostaglandin E2 antagonist | |||
| 0.119 | 0.018 | 0.119 | mTOR complex 2 inhibitor | 0.107 0.026 CID_57515736 | ||
| 0.112 | 0.011 | 0.112 | Potassium channel (ATP-sensitive) blocker | 0.063 0.054 CID_57515736 | ||
| 0.115 | 0.015 | 0.546 | Alcohol oxidase inhibitor | 0.546 0.003 CID_57515736 | CID_57515736 | |
| 0.136 | 0.037 | 0.144 | Activin receptor-like kinase 4 inhibitor | 0.144 0.032 CID_57515736 | CID_57515736 | |
| 0.156 | 0.057 | 0.156 | Histone deacetylase SIRT1 inhibitor | |||
| 0.139 | 0.041 | 0.139 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.159 | 0.064 | 0.429 | NOS3 expression enhancer | 0.429 0.007 CID_57515736 | CID_57515736 | |
| 0.199 | 0.105 | 0.312 | Aldehyde oxidase inhibitor | 0.312 0.063 CID_57515736 | CID_57515736 | |
| 0.144 | 0.051 | 0.153 | Cathepsin H inhibitor | 0.153 0.044 CID_57515736 | CID_57515736 | |
| 0.277 | 0.184 | 0.277 | Cyclophilin D inhibitor | |||
| 0.1 | 0.008 | 0.1 | Sphingosine kinase 2 inhibitor | |||
| 0.149 | 0.057 | 0.149 | Nav1.2 sodium channel blocker | |||
| 0.1 | 0.008 | 0.159 | Aconitate hydratase inhibitor | 0.159 0.004 CID_57515736 | CID_57515736 | |
| 0.11 | 0.02 | 0.146 | Aromatase inhibitor | 0.146 0.014 CID_57515736 | CID_57515736 | |
| 0.134 | 0.044 | 0.134 | 5-Lipoxygenase inhibitor | |||
| 0.17 | 0.08 | 0.17 | LIM domain kinase 1 inhibitor | 0.143 0.105 CID_57515736 | ||
| 0.099 | 0.01 | 0.099 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.199 | 0.11 | 0.199 | Tumour necrosis factor alpha release inhibitor | |||
| 0.181 | 0.092 | 0.235 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.235 0.05 CID_57515736 | CID_57515736 | |
| 0.126 | 0.037 | 0.179 | Creatine kinase inhibitor | 0.179 0.014 CID_57515736 | CID_57515736 | |
| 0.124 | 0.036 | 0.124 | Uric acid excretion stimulant | |||
| 0.15 | 0.062 | 0.15 | Sphingosine 1-phosphate receptor 5 antagonist | 0.128 0.104 CID_57515736 | ||
| 0.141 | 0.054 | 0.141 | Nav1.3 sodium channel blocker | |||
| 0.094 | 0.008 | 0.094 | Glutamate (mGluR5) agonist | 0.073 0.013 CID_57515736 | ||
| 0.113 | 0.029 | 0.113 | Acetylcholine nicotinic agonist | 0.094 0.042 CID_57515736 | ||
| 0.103 | 0.02 | 0.111 | Transforming growth factor beta 3 antagonist | 0.111 0.015 CID_57515736 | CID_57515736 | |
| 0.1 | 0.018 | 0.1 | EphB4 antagonist | |||
| 0.113 | 0.031 | 0.113 | Phosphodiesterase 4D inhibitor | |||
| 0.121 | 0.039 | 0.121 | Breast cancer-resistant protein inhibitor | |||
| 0.091 | 0.01 | 0.092 | Transcription factor RelA inhibitor | 0.092 0.009 CID_57515736 | CID_57515736 | |
| 0.116 | 0.035 | 0.116 | Epidermal growth factor antagonist | |||
| 0.095 | 0.016 | 0.095 | Protease activated receptor antagonist | |||
| 0.134 | 0.055 | 0.134 | MAP kinase 12 inhibitor | 0.107 0.087 CID_57515736 | ||
| 0.145 | 0.068 | 0.145 | MAP3K9 inhibitor | |||
| 0.094 | 0.016 | 0.094 | Aryl hydrocarbon receptor antagonist | 0.072 0.035 CID_57515736 | ||
| 0.09 | 0.013 | 0.09 | Phosphodiesterase 3B inhibitor | |||
| 0.181 | 0.105 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.087 | 0.013 | 0.087 | Cyclin D1 inhibitor | 0.07 0.028 CID_57515736 | ||
| 0.098 | 0.026 | 0.098 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.081 | 0.008 | 0.081 | Glutamate (mGluR1a) antagonist | 0.055 0.017 CID_57515736 | ||
| 0.083 | 0.011 | 0.083 | Glutamate (mGluR group I) agonist | 0.069 0.017 CID_57515736 | ||
| 0.181 | 0.11 | 0.281 | Cyclic AMP phosphodiesterase inhibitor | 0.281 0.049 CID_57515736 | CID_57515736 | |
| 0.096 | 0.026 | 0.096 | Neuronal nicotinic receptor antagonist | 0.089 0.03 CID_57515736 | ||
| 0.073 | 0.004 | 0.073 | Guanylate cyclase inhibitor | 0.051 0.02 CID_57515736 | ||
| 0.179 | 0.111 | 0.179 | Dyrk kinase inhibitor | |||
| 0.084 | 0.016 | 0.084 | Phosphodiesterase 1C inhibitor | 0.061 0.045 CID_57515736 | ||
| 0.075 | 0.007 | 0.075 | Glutamate (mGluR group II) antagonist | 0.038 0.027 CID_57515736 | ||
| 0.08 | 0.013 | 0.08 | H+/K+-transporting ATPase inhibitor | |||
| 0.104 | 0.036 | 0.104 | MAP-kinase-activated kinase inhibitor | 0.099 0.04 CID_57515736 | ||
| 0.093 | 0.026 | 0.093 | Phosphodiesterase III inhibitor | |||
| 0.076 | 0.009 | 0.076 | Guanylate cyclase stimulant | |||
| 0.077 | 0.01 | 0.077 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.122 | 0.056 | 0.122 | TRPA1 agonist | 0.122 0.056 CID_57515736 | ||
| 0.105 | 0.039 | 0.105 | Phosphodiesterase I inhibitor | |||
| 0.107 | 0.04 | 0.107 | Phosphodiesterase 6D inhibitor | 0.093 0.068 CID_57515736 | ||
| 0.092 | 0.025 | 0.092 | Leukotriene antagonist | |||
| 0.265 | 0.199 | 0.265 | Apoptosis agonist | |||
| 0.074 | 0.008 | 0.074 | Purinergic P2X4 antagonist | 0.045 0.032 CID_57515736 | ||
| 0.074 | 0.008 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.058 0.03 CID_57515736 | ||
| 0.089 | 0.023 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.1 0.014 CID_57515736 | CID_57515736 | |
| 0.224 | 0.159 | 0.224 | Vasodilator, coronary | |||
| 0.071 | 0.007 | 0.071 | Prostacyclin antagonist | |||
| 0.081 | 0.017 | 0.081 | Histone deacetylase SIRT3 inhibitor | |||
| 0.136 | 0.071 | 0.136 | Amylase inhibitor | 0.129 0.075 CID_57515736 | ||
| 0.081 | 0.016 | 0.081 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.179 | 0.115 | 0.179 | Antiamyloidogenic | 0.156 0.139 CID_57515736 | ||
| 0.131 | 0.067 | 0.131 | Toll-Like receptor 2 antagonist | 0.113 0.085 CID_57515736 | ||
| 0.118 | 0.055 | 0.155 | GABA C receptor antagonist | 0.155 0.028 CID_57515736 | CID_57515736 | |
| 0.105 | 0.042 | 0.105 | Thioredoxin inhibitor | 0.105 0.043 CID_57515736 | ||
| 0.142 | 0.079 | 0.142 | Hemostatic | |||
| 0.094 | 0.032 | 0.094 | MAP-kinase-activated kinase 2 inhibitor | 0.089 0.035 CID_57515736 | ||
| 0.082 | 0.021 | 0.082 | Phosphodiesterase 1B inhibitor | |||
| 0.108 | 0.048 | 0.108 | Interleukin 1 beta converting enzyme inhibitor | 0.093 0.067 CID_57515736 | ||
| 0.197 | 0.138 | 0.197 | Transcription factor STAT3 inhibitor | |||
| 0.149 | 0.09 | 0.209 | Arachidonic acid antagonist | 0.209 0.025 CID_57515736 | CID_57515736 | |
| 0.074 | 0.015 | 0.074 | Lysine-specific demethylase 1A inhibitor | |||
| 0.077 | 0.019 | 0.077 | Toll-Like receptor 8 antagonist | 0.049 0.042 CID_57515736 | ||
| 0.08 | 0.022 | 0.08 | GABA A receptor antagonist | 0.066 0.027 CID_57515736 | ||
| 0.102 | 0.045 | 0.102 | Insulin growth factor antagonist | |||
| 0.104 | 0.046 | 0.104 | Protein kinase C zeta inhibitor | 0.1 0.051 CID_57515736 | ||
| 0.076 | 0.019 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | 0.055 0.034 CID_57515736 | ||
| 0.102 | 0.045 | 0.102 | Bile acid receptor antagonist | |||
| 0.104 | 0.048 | 0.104 | Interleukin 12 antagonist | |||
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR2) antagonist | 0.029 0.022 CID_57515736 | ||
| 0.071 | 0.015 | 0.071 | Glutamate (mGluR group III) agonist | 0.054 0.021 CID_57515736 | ||
| 0.119 | 0.064 | 0.119 | Calcium channel N-type blocker | |||
| 0.096 | 0.042 | 0.096 | Acetylcholine nicotinic antagonist | 0.091 0.045 CID_57515736 | ||
| 0.069 | 0.015 | 0.069 | Squalene epoxidase inhibitor | |||
| 0.104 | 0.051 | 0.104 | Glutamate (mGluR7) agonist | |||
| 0.075 | 0.022 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.031 CID_57515736 | ||
| 0.12 | 0.068 | 0.12 | Alkylator | 0.101 0.088 CID_57515736 | ||
| 0.092 | 0.04 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.078 0.075 CID_57515736 | ||
| 0.097 | 0.044 | 0.097 | Insulin like growth factor 1 antagonist | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | 0.054 0.006 CID_57515736 | ||
| 0.075 | 0.023 | 0.075 | GABA receptor antagonist | 0.065 0.028 CID_57515736 | ||
| 0.106 | 0.055 | 0.139 | UDP-glucose 4-epimerase inhibitor | 0.139 0.033 CID_57515736 | CID_57515736 | |
| 0.135 | 0.085 | 0.164 | Pregnane X receptor agonist | 0.164 0.032 CID_57515736 | CID_57515736 | |
| 0.113 | 0.062 | 0.113 | DNA intercalator | |||
| 0.055 | 0.005 | 0.055 | CF transmembrane conductance regulator antagonist | |||
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | |||
| 0.143 | 0.094 | 0.217 | Heat shock protein 90 alpha antagonist | 0.217 0.04 CID_57515736 | CID_57515736 | |
| 0.231 | 0.182 | 0.301 | 15-Lipoxygenase inhibitor | 0.301 0.132 CID_57515736 | CID_57515736 | |
| 0.136 | 0.088 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.037 CID_57515736 | CID_57515736 | |
| 0.209 | 0.161 | 0.253 | Transcription factor NF kappa B inhibitor | 0.253 0.125 CID_57515736 | CID_57515736 | |
| 0.081 | 0.033 | 0.081 | Orexin receptor 1 antagonist | 0.074 0.045 CID_57515736 | ||
| 0.071 | 0.024 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 CID_57515736 | CID_57515736 | |
| 0.169 | 0.122 | 0.169 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.156 0.135 CID_57515736 | ||
| 0.061 | 0.014 | 0.061 | DNA-dependent protein kinase inhibitor | |||
| 0.078 | 0.031 | 0.078 | Glutamate (mGluR) agonist | |||
| 0.055 | 0.008 | 0.055 | Heme oxygenase inhibitor | 0.044 0.027 CID_57515736 | ||
| 0.135 | 0.088 | 0.135 | Thiol protease inhibitor | |||
| 0.131 | 0.085 | 0.131 | CDC-like kinase 1 inhibitor | |||
| 0.059 | 0.013 | 0.059 | G protein-coupled receptor agonist | |||
| 0.081 | 0.035 | 0.081 | Phosphodiesterase 4B inhibitor | 0.063 0.052 CID_57515736 | ||
| 0.07 | 0.025 | 0.07 | Sphingosine kinase inhibitor | |||
| 0.065 | 0.02 | 0.065 | Leukotriene C antagonist | |||
| 0.065 | 0.021 | 0.065 | Plasminogen activator inhibitor antagonist | |||
| 0.063 | 0.019 | 0.063 | CD45 antagonist | |||
| 0.069 | 0.025 | 0.069 | Phosphodiesterase 4A inhibitor | |||
| 0.082 | 0.04 | 0.082 | Adenosine A3 receptor antagonist | |||
| 0.137 | 0.095 | 0.137 | Hexokinase inhibitor | 0.137 0.095 CID_57515736 | ||
| 0.068 | 0.027 | 0.068 | Phosphodiesterase 1A inhibitor | 0.057 0.048 CID_57515736 | ||
| 0.09 | 0.049 | 0.09 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.055 | 0.014 | 0.055 | Dihydrofolate reductase inhibitor | |||
| 0.143 | 0.103 | 0.143 | Antipruritic | 0.141 0.105 CID_57515736 | ||
| 0.191 | 0.151 | 0.191 | Transcription factor STAT inhibitor | 0.191 0.151 CID_57515736 | ||
| 0.12 | 0.08 | 0.12 | Tubulin antagonist | |||
| 0.106 | 0.067 | 0.106 | Protein kinase C gamma inhibitor | 0.101 0.075 CID_57515736 | ||
| 0.092 | 0.052 | 0.101 | Bromodomain-containing protein 2 inhibitor | 0.101 0.039 CID_57515736 | CID_57515736 | |
| 0.147 | 0.11 | 0.218 | Amyloid beta aggregation inhibitor | 0.218 0.069 CID_57515736 | CID_57515736 | |
| 0.109 | 0.072 | 0.169 | Photosensitizer | 0.169 0.022 CID_57515736 | CID_57515736 | |
| 0.046 | 0.009 | 0.046 | Uridine phosphorylase inhibitor | |||
| 0.136 | 0.099 | 0.172 | Interferon gamma antagonist | 0.172 0.056 CID_57515736 | CID_57515736 | |
| 0.178 | 0.141 | 0.193 | Interleukin agonist | 0.193 0.127 CID_57515736 | CID_57515736 | |
| 0.055 | 0.019 | 0.055 | Benzodiazepine inverse agonist | 0.055 0.019 CID_57515736 | ||
| 0.058 | 0.022 | 0.058 | Phosphodiesterase X inhibitor | |||
| 0.058 | 0.022 | 0.058 | Phosphodiesterase 10A inhibitor | |||
| 0.147 | 0.112 | 0.158 | Phospholipase C inhibitor | 0.158 0.092 CID_57515736 | CID_57515736 | |
| 0.069 | 0.034 | 0.069 | Prostaglandin EP2 antagonist | |||
| 0.079 | 0.043 | 0.079 | Phosphodiesterase VI inhibitor | 0.071 0.06 CID_57515736 | ||
| 0.195 | 0.16 | 0.195 | Prostaglandin dehydrogenase inhibitor | |||
| 0.09 | 0.056 | 0.1 | NADH dehydrogenase inhibitor | 0.1 0.044 CID_57515736 | CID_57515736 | |
| 0.052 | 0.018 | 0.052 | Urate transporter 1 inhibitor | |||
| 0.066 | 0.031 | 0.066 | Nicotinic neuronal receptor agonist | 0.05 0.045 CID_57515736 | ||
| 0.075 | 0.041 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.068 | 0.034 | 0.068 | TRPA1 antagonist | |||
| 0.073 | 0.039 | 0.073 | Fibroblast growth factor 2 antagonist | |||
| 0.052 | 0.018 | 0.052 | Liver X receptor alpha agonist | |||
| 0.189 | 0.156 | 0.275 | Tyrosine 3 hydroxylase inhibitor | 0.275 0.048 CID_57515736 | CID_57515736 | |
| 0.041 | 0.008 | 0.041 | Thiazolidinedione | |||
| 0.053 | 0.021 | 0.053 | Benzodiazepine antagonist | 0.048 0.031 CID_57515736 | ||
| 0.131 | 0.098 | 0.131 | Neuropeptide Y1 antagonist | |||
| 0.037 | 0.004 | 0.037 | G-protein-coupled receptor 120 agonist | |||
| 0.073 | 0.041 | 0.088 | Acetylcholine M5 receptor agonist | 0.088 0.028 CID_57515736 | CID_57515736 | |
| 0.047 | 0.015 | 0.047 | Glutamate (mGluR3) antagonist | 0.037 0.024 CID_57515736 | ||
| 0.078 | 0.046 | 0.078 | GABA B receptor agonist | 0.073 0.059 CID_57515736 | ||
| 0.057 | 0.026 | 0.06 | Alpha 1L adrenoreceptor antagonist | 0.06 0.022 CID_57515736 | CID_57515736 | |
| 0.113 | 0.082 | 0.113 | TRKB antagonist | |||
| 0.046 | 0.015 | 0.046 | Delayed rectifier potassium channel blocker | |||
| 0.08 | 0.049 | 0.08 | Glutamate (mGluR) antagonist | 0.078 0.051 CID_57515736 | ||
| 0.074 | 0.043 | 0.074 | Toll-Like receptor 7 antagonist | |||
| 0.052 | 0.022 | 0.052 | Cathepsin L2 inhibitor | |||
| 0.043 | 0.013 | 0.043 | Liver X receptor beta agonist | |||
| 0.09 | 0.06 | 0.105 | Triose-phosphate isomerase inhibitor | 0.105 0.043 CID_57515736 | CID_57515736 | |
| 0.049 | 0.021 | 0.049 | Leukotriene A4 hydrolase inhibitor | |||
| 0.058 | 0.03 | 0.058 | Leukotriene B4 antagonist | |||
| 0.052 | 0.024 | 0.052 | CC chemokine 4 receptor antagonist | |||
| 0.04 | 0.012 | 0.04 | Liver X receptor beta antagonist | |||
| 0.067 | 0.039 | 0.083 | 5 Hydroxytryptamine 3 agonist | 0.083 0.024 CID_57515736 | CID_57515736 | |
| 0.066 | 0.038 | 0.068 | Calcium channel P-type blocker | 0.068 0.033 CID_57515736 | CID_57515736 | |
| 0.033 | 0.006 | 0.033 | Imidazoline I1 receptor antagonist | |||
| 0.071 | 0.045 | 0.071 | Carbonic anhydrase VA inhibitor | |||
| 0.06 | 0.034 | 0.06 | Phosphodiesterase 4C inhibitor | |||
| 0.03 | 0.004 | 0.03 | Alpha 2b adrenoreceptor agonist | 0.03 0.004 CID_57515736 | ||
| 0.031 | 0.006 | 0.031 | Free fatty acid receptor 1 agonist | |||
| 0.062 | 0.037 | 0.062 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.053 | 0.028 | 0.067 | Topoisomerase II beta inhibitor | 0.067 0.018 CID_57515736 | CID_57515736 | |
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR4) agonist | 0.038 0.017 CID_57515736 | ||
| 0.066 | 0.042 | 0.066 | CDC25B inhibitor | |||
| 0.101 | 0.077 | 0.101 | CDC-like kinase 3 inhibitor | |||
| 0.057 | 0.033 | 0.057 | Alpha tubulin antagonist | |||
| 0.092 | 0.068 | 0.092 | Platelet activating factor beta antagonist | |||
| 0.074 | 0.05 | 0.074 | Histone deacetylase stimulant | |||
| 0.074 | 0.05 | 0.074 | Histone deacetylase SIRT1 stimulant | |||
| 0.037 | 0.014 | 0.037 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 CID_57515736 | ||
| 0.104 | 0.082 | 0.105 | Cholesterol synthesis inhibitor | 0.105 0.081 CID_57515736 | CID_57515736 | |
| 0.07 | 0.048 | 0.07 | Transforming growth factor antagonist | 0.07 0.047 CID_57515736 | ||
| 0.057 | 0.034 | 0.057 | Epithelial sodium channel blocker | |||
| 0.059 | 0.037 | 0.066 | Fatty acid synthase inhibitor | 0.066 0.029 CID_57515736 | CID_57515736 | |
| 0.055 | 0.033 | 0.055 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.032 | 0.011 | 0.032 | Myristoyl transferase inhibitor | |||
| 0.034 | 0.013 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 CID_57515736 | ||
| 0.042 | 0.021 | 0.042 | Leukotriene C4 antagonist | |||
| 0.081 | 0.06 | 0.081 | Glutathione S-transferase inhibitor | |||
| 0.077 | 0.056 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.033 CID_57515736 | CID_57515736 | |
| 0.056 | 0.035 | 0.056 | Thromboxane synthase inhibitor | 0.053 0.041 CID_57515736 | ||
| 0.134 | 0.114 | 0.134 | CDC-like kinase 4 inhibitor | |||
| 0.044 | 0.024 | 0.044 | Plasmepsin II inhibitor | |||
| 0.024 | 0.004 | 0.024 | Granulocyte colony stimulating factor receptor agonist | 0.02 0.008 CID_57515736 | ||
| 0.039 | 0.019 | 0.039 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.054 | 0.034 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 CID_57515736 | ||
| 0.044 | 0.024 | 0.044 | Sphingosine kinase 1 inhibitor | |||
| 0.109 | 0.09 | 0.149 | Alpha-N-acetylglucosaminidase inhibitor | 0.149 0.056 CID_57515736 | CID_57515736 | |
| 0.038 | 0.019 | 0.038 | Ceramide glucosyltransferase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Glucosylceramidase inhibitor | |||
| 0.066 | 0.047 | 0.066 | Orexin receptor antagonist | |||
| 0.054 | 0.036 | 0.054 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.052 | 0.034 | 0.052 | Prolyl endopeptidase inhibitor | |||
| 0.141 | 0.123 | 0.141 | Clk dual-specificity kinase inhibitor | |||
| 0.091 | 0.074 | 0.091 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.059 | 0.041 | 0.059 | Ryanodine receptor antagonist | 0.058 0.045 CID_57515736 | ||
| 0.04 | 0.023 | 0.04 | Diamine oxidase inhibitor | |||
| 0.044 | 0.027 | 0.046 | GABA B receptor antagonist | 0.046 0.024 CID_57515736 | CID_57515736 | |
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.112 | 0.096 | 0.12 | Alkaline phosphatase inhibitor | 0.12 0.086 CID_57515736 | CID_57515736 | |
| 0.079 | 0.062 | 0.079 | ErbB-3 antagonist | |||
| 0.046 | 0.03 | 0.046 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.028 CID_57515736 | ||
| 0.055 | 0.039 | 0.055 | MAP kinase kinase 9 inhibitor | |||
| 0.026 | 0.011 | 0.026 | Prostaglandin EP1 antagonist | |||
| 0.088 | 0.073 | 0.088 | MAP kinase kinase 1 inhibitor | 0.086 0.076 CID_57515736 | ||
| 0.044 | 0.029 | 0.059 | Glutamate (mGluR group III) antagonist | 0.059 0.014 CID_57515736 | CID_57515736 | |
| 0.064 | 0.049 | 0.064 | Carbonic anhydrase V inhibitor | |||
| 0.059 | 0.044 | 0.066 | Alpha 2 adrenoreceptor agonist | 0.066 0.035 CID_57515736 | CID_57515736 | |
| 0.092 | 0.077 | 0.092 | Topoisomerase I inhibitor | |||
| 0.123 | 0.109 | 0.193 | Heat shock protein 90 antagonist | 0.193 0.041 CID_57515736 | CID_57515736 | |
| 0.019 | 0.005 | 0.019 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.047 | 0.033 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.023 | 0.01 | 0.023 | Guanylate cyclase 1 stimulant | |||
| 0.032 | 0.018 | 0.042 | Nicotinic alpha3beta4 receptor agonist | 0.042 0.009 CID_57515736 | CID_57515736 | |
| 0.059 | 0.045 | 0.059 | Purinergic P2X1 antagonist | 0.057 0.049 CID_57515736 | ||
| 0.092 | 0.079 | 0.112 | Hedgehog signaling inhibitor | 0.112 0.048 CID_57515736 | CID_57515736 | |
| 0.098 | 0.085 | 0.098 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.054 | 0.042 | 0.054 | Adenine nucleotide translocase inhibitor | |||
| 0.067 | 0.054 | 0.094 | Histidine decarboxylase inhibitor | 0.094 0.034 CID_57515736 | CID_57515736 | |
| 0.188 | 0.176 | 0.251 | Insulysin inhibitor | 0.251 0.096 CID_57515736 | CID_57515736 | |
| 0.017 | 0.004 | 0.017 | Imidazoline I2 receptor antagonist | |||
| 0.097 | 0.085 | 0.097 | Vascular endothelial growth factor antagonist | |||
| 0.038 | 0.026 | 0.038 | Farnesoid X receptor agonist | |||
| 0.036 | 0.024 | 0.036 | ATM kinase inhibitor | |||
| 0.069 | 0.058 | 0.069 | Nav1.8 sodium channel blocker | |||
| 0.153 | 0.142 | 0.153 | MAP kinase kinase 5 inhibitor | |||
| 0.021 | 0.01 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 CID_57515736 | ||
| 0.081 | 0.071 | 0.081 | Interleukin 5 antagonist | |||
| 0.079 | 0.068 | 0.079 | Histamine H2 receptor antagonist | |||
| 0.028 | 0.017 | 0.028 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.076 | 0.066 | 0.076 | I kappa B kinase inhibitor | |||
| 0.033 | 0.023 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.038 | 0.029 | 0.038 | Aggrecanase 1 inhibitor | |||
| 0.075 | 0.066 | 0.075 | MAP kinase 7 inhibitor | |||
| 0.057 | 0.048 | 0.057 | Potassium channel (Ca-activated) blocker | |||
| 0.021 | 0.013 | 0.021 | Hexokinase stimulant | |||
| 0.026 | 0.018 | 0.026 | Leukotriene D4 antagonist | |||
| 0.079 | 0.071 | 0.079 | Falcipain 2 inhibitor | |||
| 0.037 | 0.029 | 0.058 | Potassium channel Kv1.1 blocker | 0.058 0.009 CID_57515736 | CID_57515736 | |
| 0.098 | 0.09 | 0.098 | Proteasome inhibitor | |||
| 0.032 | 0.024 | 0.032 | Sirtuin 2 inhibitor | |||
| 0.118 | 0.11 | 0.118 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.03 | 0.022 | 0.03 | Cyclophilin A inhibitor | |||
| 0.122 | 0.114 | 0.122 | Phospholipase A2 inhibitor | |||
| 0.081 | 0.073 | 0.081 | Falcipain inhibitor | |||
| 0.127 | 0.119 | 0.127 | Dual specificity phosphatase 3 inhibitor | |||
| 0.019 | 0.011 | 0.019 | Complement factor D inhibitor | |||
| 0.058 | 0.051 | 0.058 | I kappa B kinase 2 inhibitor | |||
| 0.051 | 0.044 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.029 | 0.022 | 0.029 | Prostaglandin EP3 antagonist | |||
| 0.065 | 0.058 | 0.065 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.014 | 0.007 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.047 | 0.04 | 0.047 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.029 | 0.023 | 0.029 | Bradykinin B2 receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.068 | 0.062 | 0.068 | ErbB-4 antagonist | |||
| 0.016 | 0.011 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.013 CID_57515736 | ||
| 0.106 | 0.101 | 0.106 | Tyrosine-protein kinase receptor antagonist | |||
| 0.099 | 0.094 | 0.099 | Caspase 3 inhibitor | |||
| 0.139 | 0.135 | 0.193 | Succinate dehydrogenase inhibitor | 0.193 0.055 CID_57515736 | CID_57515736 | |
| 0.036 | 0.032 | 0.036 | Dihydropteroate synthase inhibitor | |||
| 0.075 | 0.071 | 0.075 | Bcr-Abl kinase inhibitor | |||
| 0.09 | 0.087 | 0.106 | Adenylate kinase inhibitor | 0.106 0.058 CID_57515736 | CID_57515736 | |
| 0.054 | 0.05 | 0.054 | Collagenase 3 inhibitor | |||
| 0.04 | 0.037 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.048 | 0.045 | 0.048 | Autotaxin inhibitor | |||
| 0.019 | 0.017 | 0.019 | Toll-Like receptor 8 agonist | |||
| 0.015 | 0.012 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Transforming growth factor beta 2 antagonist | |||
| 0.032 | 0.03 | 0.032 | Orexin receptor 2 antagonist | |||
| 0.038 | 0.036 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.08 | 0.078 | 0.087 | Pim-3 kinase inhibitor | 0.087 0.062 CID_57515736 | CID_57515736 | |
| 0.045 | 0.044 | 0.045 | Prostaglandin antagonist | |||
| 0.062 | 0.061 | 0.062 | Glutamate (mGluR6) antagonist | 0.062 0.061 CID_57515736 | ||
| 0.043 | 0.042 | 0.043 | Cholesterol esterase inhibitor | |||
| 0.12 | 0.119 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.049 CID_57515736 | CID_57515736 | |
| 0.026 | 0.026 | 0.029 | Glucosylceramidase stimulant | 0.029 0.013 CID_57515736 | CID_57515736 | |
| 0.042 | 0.043 | 0.044 | Transforming growth factor beta 1 antagonist | 0.044 0.041 CID_57515736 | CID_57515736 | |
| 0.04 | 0.042 | 0.052 | Histamine H1 receptor agonist | 0.052 0.015 CID_57515736 | CID_57515736 | |
| 0.035 | 0.037 | 0.038 | 5 Hydroxytryptamine 2B agonist | 0.038 0.028 CID_57515736 | CID_57515736 | |
| 0.04 | 0.042 | 0.042 | Glutamate (mGluR5) antagonist | 0.042 0.038 CID_57515736 | CID_57515736 | |
| 0.039 | 0.042 | 0.042 | Adenosine deaminase inhibitor | 0.042 0.038 CID_57515736 | CID_57515736 | |
| 0.062 | 0.065 | 0.077 | Exportin-1 inhibitor | 0.077 0.03 CID_57515736 | CID_57515736 | |
| 0.046 | 0.049 | 0.052 | Nicotinic alpha7 receptor agonist | 0.052 0.04 CID_57515736 | CID_57515736 | |
| 0.004 | 0.009 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 CID_57515736 | CID_57515736 | |
| 0.061 | 0.067 | 0.094 | Aminopeptidase I inhibitor | 0.094 0.031 CID_57515736 | CID_57515736 | |
| 0.078 | 0.084 | 0.089 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.066 CID_57515736 | CID_57515736 | |
| 0.066 | 0.073 | 0.085 | Keratolytic | 0.085 0.042 CID_57515736 | CID_57515736 | |
| 0.039 | 0.046 | 0.047 | AMPA receptor antagonist | 0.047 0.034 CID_57515736 | CID_57515736 | |
| 0.038 | 0.046 | 0.043 | Glutamate (mGluR4) antagonist | 0.043 0.032 CID_57515736 | CID_57515736 | |
| 0.042 | 0.052 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.017 CID_57515736 | CID_57515736 | |
| 0.163 | 0.174 | 0.242 | 5 Hydroxytryptamine 1E antagonist | 0.242 0.083 CID_57515736 | CID_57515736 | |
| 0.012 | 0.023 | 0.036 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.036 0.008 CID_57515736 | CID_57515736 | |
| 0.024 | 0.035 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 CID_57515736 | CID_57515736 | |
| 0.089 | 0.102 | 0.14 | DOPA decarboxylase inhibitor | 0.14 0.027 CID_57515736 | CID_57515736 | |
| 0.189 | 0.202 | 0.212 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.212 0.134 CID_57515736 | CID_57515736 | |
| 0.05 | 0.064 | 0.079 | Pregnane X receptor antagonist | 0.079 0.007 CID_57515736 | CID_57515736 | |
| 0.028 | 0.042 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 CID_57515736 | CID_57515736 | |
| 0.038 | 0.057 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 CID_57515736 | CID_57515736 | |
| 0.112 | 0.132 | 0.142 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.088 CID_57515736 | CID_57515736 | |
| 0.028 | 0.047 | 0.052 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 CID_57515736 | CID_57515736 | |
| 0.026 | 0.048 | 0.031 | ATR kinase inhibitor | 0.031 0.027 CID_57515736 | CID_57515736 | |
| 0.032 | 0.054 | 0.059 | Histamine H2 receptor agonist | 0.059 0.015 CID_57515736 | CID_57515736 | |
| 0.055 | 0.078 | 0.064 | Glutamate (mGluR group I) antagonist | 0.064 0.058 CID_57515736 | CID_57515736 | |
| 0.021 | 0.044 | 0.035 | Purinergic P2Y14 antagonist | 0.035 0.015 CID_57515736 | CID_57515736 | |
| 0.131 | 0.155 | 0.148 | Death-associated protein kinase 3 inhibitor | 0.148 0.125 CID_57515736 | CID_57515736 | |
| 0.058 | 0.082 | 0.082 | Phospholipase D inhibitor | 0.082 0.032 CID_57515736 | CID_57515736 | |
| 0.069 | 0.095 | 0.119 | Aminopeptidase B inhibitor | 0.119 0.053 CID_57515736 | CID_57515736 | |
| 0.081 | 0.107 | 0.12 | Chelator | 0.12 0.053 CID_57515736 | CID_57515736 | |
| 0.05 | 0.077 | 0.068 | CDC7 inhibitor | 0.068 0.047 CID_57515736 | CID_57515736 | |
| 0.076 | 0.103 | 0.217 | GABA C receptor agonist | 0.217 0.018 CID_57515736 | CID_57515736 | |
| 0.071 | 0.099 | 0.165 | Butyrylcholinesterase inhibitor | 0.165 0.029 CID_57515736 | CID_57515736 | |
| 0.031 | 0.06 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.026 CID_57515736 | CID_57515736 | |
| 0.095 | 0.124 | 0.135 | Transcription factor STAT6 inhibitor | 0.135 0.038 CID_57515736 | CID_57515736 | |
| 0.047 | 0.078 | 0.069 | 5 Hydroxytryptamine 3A antagonist | 0.069 0.043 CID_57515736 | CID_57515736 | |
| 0.037 | 0.07 | 0.068 | Glutamate (mGluR1) antagonist | 0.068 0.032 CID_57515736 | CID_57515736 | |
| 0.119 | 0.154 | 0.226 | MAP kinase kinase 2 inhibitor | 0.226 0.066 CID_57515736 | CID_57515736 | |
| 0.03 | 0.066 | 0.041 | Dihydroorotase inhibitor | 0.041 0.037 CID_57515736 | CID_57515736 | |
| 0.068 | 0.104 | 0.088 | Prolactin inhibitor | 0.088 0.069 CID_57515736 | CID_57515736 | |
| 0.194 | 0.233 | 0.285 | Transcription factor inhibitor | 0.285 0.164 CID_57515736 | CID_57515736 | |
| 0.038 | 0.078 | 0.056 | Biliverdin reductase inhibitor | 0.056 0.045 CID_57515736 | CID_57515736 | |
| 0.042 | 0.083 | 0.072 | Phosphofructokinase-1 inhibitor | 0.072 0.046 CID_57515736 | CID_57515736 | |
| 0.03 | 0.071 | 0.044 | Nerve growth factor antagonist | 0.044 0.028 CID_57515736 | CID_57515736 | |
| 0.048 | 0.09 | 0.074 | Na+ K+ transporting ATPase inhibitor | 0.074 0.056 CID_57515736 | CID_57515736 | |
| 0.082 | 0.126 | 0.105 | Microtubule formation inhibitor | 0.105 0.082 CID_57515736 | CID_57515736 | |
| 0.057 | 0.102 | 0.077 | Potassium channel (Tandem pore domain) blocker | 0.077 0.043 CID_57515736 | CID_57515736 | |
| 0.111 | 0.157 | 0.154 | Melanin inhibitor | 0.154 0.076 CID_57515736 | CID_57515736 | |
| 0.05 | 0.097 | 0.066 | Protein kinase B beta inhibitor | 0.066 0.064 CID_57515736 | CID_57515736 | |
| 0.037 | 0.084 | 0.057 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.046 CID_57515736 | CID_57515736 | |
| 0.034 | 0.081 | 0.067 | Argininosuccinate synthase inhibitor | 0.067 0.032 CID_57515736 | CID_57515736 | |
| 0.176 | 0.223 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.292 0.087 CID_57515736 | CID_57515736 | |
| 0.008 | 0.057 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 CID_57515736 | CID_57515736 | |
| 0.043 | 0.094 | 0.079 | Heat shock protein 90 beta antagonist | 0.079 0.021 CID_57515736 | CID_57515736 | |
| 0.045 | 0.097 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.036 CID_57515736 | CID_57515736 | |
| 0.111 | 0.164 | 0.262 | Anesthetic general | 0.262 0.045 CID_57515736 | CID_57515736 | |
| 0.071 | 0.124 | 0.174 | 5 Hydroxytryptamine 3A agonist | 0.174 0.024 CID_57515736 | CID_57515736 | |
| 0.032 | 0.088 | 0.057 | Histamine agonist | 0.057 0.031 CID_57515736 | CID_57515736 | |
| 0.066 | 0.127 | 0.126 | Ferrochelatase inhibitor | 0.126 0.05 CID_57515736 | CID_57515736 | |
| 0.033 | 0.096 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 CID_57515736 | CID_57515736 | |
| 0.104 | 0.169 | 0.152 | Adenylate cyclase stimulant | 0.152 0.06 CID_57515736 | CID_57515736 | |
| 0.013 | 0.079 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.023 CID_57515736 | CID_57515736 | |
| 0.021 | 0.088 | 0.036 | Dopamine D5 agonist | 0.036 0.033 CID_57515736 | CID_57515736 | |
| 0.025 | 0.093 | 0.035 | Glutamate (mGluR8) agonist | 0.035 0.032 CID_57515736 | CID_57515736 | |
| 0.042 | 0.112 | 0.077 | Glutamate decarboxylase inhibitor | 0.077 0.047 CID_57515736 | CID_57515736 | |
| 0.074 | 0.156 | 0.191 | Acetylcholinesterase inhibitor | 0.191 0.036 CID_57515736 | CID_57515736 | |
| 0.064 | 0.151 | 0.105 | Electrolyte absorption antagonist | 0.105 0.051 CID_57515736 | CID_57515736 | |
| 0.061 | 0.15 | 0.125 | Anabolic | 0.125 0.035 CID_57515736 | CID_57515736 | |
| 0.034 | 0.129 | 0.158 | Phosphodiesterase V inhibitor | 0.158 0.009 CID_57515736 | CID_57515736 | |
| 0.034 | 0.129 | 0.163 | Phosphodiesterase 5A inhibitor | 0.163 0.009 CID_57515736 | CID_57515736 | |
| 0.051 | 0.155 | 0.07 | Vanilloid 4 agonist | 0.07 0.063 CID_57515736 | CID_57515736 | |
| 0.027 | 0.134 | 0.064 | Cyclin-dependent kinase 6 inhibitor | 0.064 0.037 CID_57515736 | CID_57515736 | |
| 0.026 | 0.143 | 0.071 | Aldosterone antagonist | 0.071 0.014 CID_57515736 | CID_57515736 | |
| 0.13 | 0.25 | 0.193 | DNA synthesis inhibitor | 0.193 0.134 CID_57515736 | CID_57515736 | |
| 0.046 | 0.168 | 0.079 | Potassium channel activator | 0.079 0.078 CID_57515736 | CID_57515736 | |
| 0.071 | 0.211 | 0.202 | Cholinergic | 0.202 0.046 CID_57515736 | CID_57515736 | |
| 0.03 | 0.173 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 CID_57515736 | CID_57515736 | |
| 0.137 | 0.321 | 0.286 | Antibacterial | 0.286 0.146 CID_57515736 | CID_57515736 | |
| 0.094 | 0.308 | 0.158 | Death-associated protein kinase 2 inhibitor | 0.158 0.089 CID_57515736 | CID_57515736 | |
| 0.105 | 0.375 | 0.409 | Toll-Like receptor 7 agonist | 0.409 0.056 CID_57515736 | CID_57515736 | |
| 0.087 | 0.363 | 0.507 | Immunosuppressant | 0.507 0.031 CID_57515736 | CID_57515736 | |
| 0.102 | 0.38 | 0.405 | Toll-Like receptor agonist | 0.405 0.058 CID_57515736 | CID_57515736 | |
| 0.004 | 0.345 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 CID_57515736 | CID_57515736 | |
| 0.005 | 0.352 | 0.049 | Glucocorticoid antagonist | 0.049 0.015 CID_57515736 | CID_57515736 | |
| 0.03 | 0.393 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_57515736 | CID_57515736 | |
| 0.01 | 0.415 | 0.067 | Mineralocorticoid receptor antagonist | 0.067 0.016 CID_57515736 | CID_57515736 | |
| 0.032 | 0.456 | 0.067 | Prolactin release inhibitor | 0.067 0.03 CID_57515736 | CID_57515736 | |
| 0.051 | 0.607 | 0.308 | Lipocortins synthesis antagonist | 0.308 0.02 CID_57515736 | CID_57515736 | |
| 0.002 | 0.568 | 0.02 | Progesterone agonist | 0.02 0.011 CID_57515736 | CID_57515736 | |
| 0.001 | 0.676 | 0.03 | RNA-directed RNA polymerase stimulant | 0.03 0.021 CID_57515736 | CID_57515736 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |